adenine has been researched along with tanespimycin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Burrows, F; Lundgren, K; Shores, CG; Wilson, L; Yin, X; Zhang, H | 1 |
| Burrows, F; Lough, R; Lundgren, K; Neely, L; Timple, N; Yang, YC; Zhang, H | 1 |
| Chrysikos, D; Dimopoulos, MA; Papadimitriou, CA; Psaltopoulou, T; Sergentanis, TN; Zagouri, F | 1 |
| Li, G; Li, M; Li, Z; Liu, P; Liu, Y; Liu, Z; Ma, L; Shao, W; Sui, D; Wang, B | 1 |
| Bao, H; Chen, F; Violetta, L; Xie, H; Zheng, S | 1 |
| Barua, S; Huang, MY; Kim, JY; Lee, JE; Park, J; Yenari, MA | 1 |
2 review(s) available for adenine and tanespimycin
| Article | Year |
|---|---|
Hsp90 inhibitors in breast cancer: a systematic review.
Topics: Adenine; Antineoplastic Agents; Benzamides; Benzoquinones; Biomarkers, Tumor; Female; Glycine; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Indazoles; Isoxazoles; Lactams, Macrocyclic; Pyridines; Resorcinols; Triazoles; Triple Negative Breast Neoplasms | 2013 |
Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection after Brain Injury.
Topics: Adenine; Animals; Benzoquinones; Brain; Brain Injuries, Traumatic; Cell Death; Disease Models, Animal; Gene Expression Regulation; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Neurons; Neuroprotective Agents; Protein Aggregates; Protein Folding; Pyridines | 2020 |
4 other study(ies) available for adenine and tanespimycin
| Article | Year |
|---|---|
BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy.
Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Head and Neck Neoplasms; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Pyridines; Radiation Tolerance; Radiation-Sensitizing Agents; Xenograft Model Antitumor Assays | 2010 |
BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance.
Topics: Adenine; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoquinones; Blotting, Western; Cell Line, Tumor; Drug Resistance, Multiple; Female; Flow Cytometry; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasms, Experimental; Pyridines; Xenograft Model Antitumor Assays | 2010 |
17AAG improves histological and functional outcomes in a rat CCI model through autophagy activation and apoptosis attenuation.
Topics: Adenine; Animals; Apoptosis; Autophagy; Benzoquinones; Brain Edema; Brain Injuries; Cell Survival; Cerebral Cortex; Female; Lactams, Macrocyclic; Motor Skills; Neurons; Neuroprotective Agents; Rats, Sprague-Dawley; Sirolimus | 2015 |
Combination of HSP90 and autophagy inhibitors promotes hepatocellular carcinoma apoptosis following incomplete thermal ablation.
Topics: Adenine; Animals; Apoptosis; Autophagy; Benzoquinones; Carcinoma, Hepatocellular; Cell Line, Tumor; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Laser Therapy; Liver Neoplasms; Mice, Nude | 2020 |